首页> 外文OA文献 >The Efficacy of Natalizumab versus Fingolimod for Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review, Indirect Evidence from Randomized Placebo-Controlled Trials and Meta-Analysis of Observational Head-to-Head Trials.

【2h】

The Efficacy of Natalizumab versus Fingolimod for Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review, Indirect Evidence from Randomized Placebo-Controlled Trials and Meta-Analysis of Observational Head-to-Head Trials.

机译：纳他珠单抗与芬戈莫德对复发缓解型多发性硬化患者的疗效：系统评价，随机安慰剂对照试验的间接证据和观察性头对头试验的meta分析。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Georgios Tsivgoulis; Aristeidis H Katsanos; Dimitris Mavridis; Nikolaos Grigoriadis; Efthymios Dardiotis; Ioannis Heliopoulos; Panagiotis Papathanasopoulos; Theodoros Karapanayiotides; Constantinos Kilidireas; Georgios M Hadjigeorgiou; Konstantinos Voumvourakis;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. THE RAPID EFFICACY OF NATALIZUMAB VS FINGOLIMOD IN PATIENTS WITH ACTIVE RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS): RESULTS FROM REVEAL, A RANDOMISED, HEAD-TO-HEAD STUDY [J] . Butzkueven Helmut, Jeffery Douglas, Arnold Douglas L., Journal of Neurology, Neurosurgery and Psychiatry . 2018,第6期

机译：Natalizumab VS Fingolimod在患有活性复发延迟多发性硬化症（RRMS）的患者中的快速疗效：结果来自揭示，随机的头部到头研究
2. Different Doses of Fingolimod in Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials [J] . Xin Wu, Tao Xue, Zilan Wang, Frontiers in Neuropharmacology . 2021,第a期

机译：不同剂量的Fingolimod在复发 - 延长多发性硬化症中：随机对照试验的系统评价和荟萃分析
3. Corrections to Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): A double-blind, randomised, placebo-controlled, phase 3 trial. [Lancet Neurol 13 (2014) 545-56] [J] . Lancet Neurology . 2014,第6期

机译：芬戈莫德在复发缓解型多发性硬化症患者中的安全性和有效性的校正（FREEDOMS II）：一项双盲，随机，安慰剂对照的3期临床试验。 [Lancet Neurol 13（2014）545-56]
4. Stroke unit of integrative medicine for post stroke comorbid anxiety and depression: A systematic review and meta-analysis of 25 randomized controlled trials [C] . Lingfeng Zeng, Changrong Meng, Zhaohui Liang, IEEE International Conference on Bioinformatics and Biomedicine . 2014

机译：中风后合并焦虑和抑郁的中西医结合卒中科：25项随机对照试验的系统评价和荟萃分析
5. Meta-Analysis: Risk of Tics with Psychostimulant Use in Randomized, Placebo-Controlled Trials. [D] . Cohen, Stephanie Celeste. 2016

机译：荟萃分析：在随机，安慰剂对照试验中使用精神兴奋药可能导致抽搐。
6. The Efficacy of Natalizumab versus Fingolimod for Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review Indirect Evidence from Randomized Placebo-Controlled Trials and Meta-Analysis of Observational Head-to-Head Trials [O] . Georgios Tsivgoulis, Aristeidis H. Katsanos, Dimitris Mavridis, -1

机译：纳他珠单抗与芬戈莫德治疗复发缓解型多发性硬化症的疗效：系统评价随机安慰剂对照试验的间接证据和观察性头对头试验的荟萃分析。
7. Natalizumab versus fingolimod for patients with active relapsing-remitting multiple sclerosis: results from REVEAL, a prospective, randomised head-to-head study [O] . Helmut Butzkueven, Stephanie Licata, Douglas Jeffery, 2020

机译：Natalizumab与Fingolimod用于有效复发 - 延髓多发性硬化症：结果来自揭示，一项潜在随机的头脑研究

The Efficacy of Natalizumab versus Fingolimod for Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review, Indirect Evidence from Randomized Placebo-Controlled Trials and Meta-Analysis of Observational Head-to-Head Trials.

著录项

相似文献

相关主题

期刊订阅